InvestorsHub Logo
Followers 7
Posts 789
Boards Moderated 0
Alias Born 11/20/2003

Re: ronpopeil post# 66

Wednesday, 01/11/2017 11:11:10 AM

Wednesday, January 11, 2017 11:11:10 AM

Post# of 428
PTGEF also owns 100 percent of PPL that houses their cell transporter technology platform, also they own part of Sentinel part of Biohaven and now the spinoff
of the ophthalmology company with Dr Littman for dry eye disease.

As the details of the $80 M raise was sketchy I noticed Dr Bailey bought part of it and Ven rock not sure if Portage bought any of it and whether they unlicensed their two phase 3 drugs to PFE and BGS
as there is no definitive breakdown as to


how this was structured.

Yes it is difficult value all of these portions of each of these companies and when PTGEF will get any respect by Mr market

Though I think that the catalysts will be
the results of these two Phase 3 studies by Biohaven .

I don't know how ptgef can raise additional equity capital as there is a lot of stock outstanding. After these catalysts they would have a better chance unless they grow each of these companies and then sell their stakes.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent PRTG News